The Growing Research Antibodies Market Driven by Advancements in Antibody-based Therapeutics
The research antibodies market plays a pivotal role in facilitating advancements across various therapeutic and diagnostic areas through its wide range of antibody-based solutions. Research antibodies find applications in various techniques including flow cytometry, immunohistochemistry, western blotting, and immunofluorescence that help scientists gain insights into biological systems at molecular and cellular levels. These antibodies are used in research applications involving cancer research, infectious diseases, immunology and inflammation research, neurological disorders, and other therapeutic areas.
Global research antibodies market is estimated to be valued at USD 11.91 Bn in 2024 and is expected to reach USD 18.60 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.
Key Takeaways
Key players operating in the research antibodies market include Thermo Fisher Scientific, Inc., Merck KGaA (including Sigma-Aldrich), Abcam plc, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Lonza Group AG, GenScript Biotech Corporation, BioLegend, Inc., Bio-Techne Corporation, F. Hoffmann-La Roche Ltd, Santa Cruz Biotechnology, Inc., BD Biosciences (Becton, Dickinson and Company), PerkinElmer, Inc., Active Motif, QIAGEN N.V., OriGene Technologies, Inc., Jackson ImmunoResearch Laboratories, Inc., RandD Systems (part of Bio-Teachne Corporation), Proteintech Group, Inc.
Growing demand for research antibodies:
The rising investments in biological and medical research by both public and private organizations is fueling the Research Antibodies Market Demand significantly. The surge in demand for research antibodies is owing to its widespread applications across various research areas including genomics, proteomics, drug discovery, and pharmacokinetic studies.
Global expansion of the research antibodies market:
The market players are actively engaging in new product launches, collaborations, and geographic expansions to strengthen their presence globally. Besides strong foothold in developed markets, key players are targeting high growth markets such as Asia Pacific and Middle East & Africa. In addition, growing R&D infrastructure and increasing healthcare expenditure in emerging nations are creating new revenue pockets for research antibodies market.
Market Key Trends
The increasing commercial production of monoclonal antibodies and advancement in antibody engineering will continue to drive the research antibodies market over the forecast period. Monoclonal antibodies are being used extensively as therapeutic antibodies for cancer, autoimmune disorders, and other chronic diseases. The growing preference for humanized and chimeric antibodies is also supporting research activities. With technological advancements, monoclonal antibodies with higher specificity and affinity are being developed through methods such as phage display, yeast display, and ribosome display.
Porter’s Analysis
Threat of new entrants: Low barrier to entry in terms of production and supply but well established players have strong brand image and distribution networks.
Bargaining power of buyers: Medium to large biotech and pharmaceutical companies have significant bargaining power due to their size and purchase volumes.
Bargaining power of suppliers: Suppliers of raw materials like antibodies have low bargaining power due to availability of substitutes.
Threat of new substitutes: Threat is medium as new technologies like monoclonal antibodies are replacing polyclonal antibodies.
Competitive rivalry: High as the market is consolidated with top players having major market share however small players compete on customization and pricing.
Geographical regions
North America accounts for the largest share of the Research Antibodies Market Regional Analysis in terms value due to presence of major players and high R&D expenditure. The United States holds majority of the market share in the region due to large biopharmaceutical industry.
Asia Pacific is the fastest growing regional market driven by increasing government investments and expansion strategies by major players in emerging countries like China and India. Rising biomedical research in academic institutes and growing biotechnology industry is supporting the market growth.
Discover the language that resonates with you:
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Spellen
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness